Long-Term Safety, Efficacy, and Patient-Centered Outcomes of Filgotinib in the Treatment of Rheumatoid Arthritis: Current Perspectives

por Tanaka, Yoshiya, Genovese, Mark C, Matsushima, Hironori
Publicado 2023

A randomized, controlled trial of interferon-β-1a (Avonex(®)) in patients with rheumatoid arthritis: a pilot study [ISRCTN03626626]

por Genovese, Mark C, Chakravarty, Eliza F, Krishnan, Eswar, Moreland, Larry W
Publicado 2004

Long-term safety, immunogenicity and efficacy comparing FKB327 with the adalimumab reference product in patients with active rheumatoid arthritis: data from randomised double-blind...

por Genovese, Mark C, Kellner, Herbert, Arai, Yasumasa, Muniz, Rafael, Alten, Rieke
Publicado 2020

Results of a proof of concept, double-blind, randomized trial of a second generation antisense oligonucleotide targeting high-sensitivity C-reactive protein (hs-CRP) in rheumatoid...

por Warren, Marshelle S, Hughes, Steven G, Singleton, Walter, Yamashita, Mason, Genovese, Mark C
Publicado 2015

Long-Term Safety of Subcutaneous Abatacept in Rheumatoid Arthritis: Integrated Analysis of Clinical Trial Data Representing More Than Four Years of Treatment

por Alten, Rieke, Kaine, Jeffrey, Keystone, Edward, Nash, Peter, Delaet, Ingrid, Genovese, Mark C
Publicado 2014

Immunogenicity of an adalimumab biosimilar, FKB327, and its reference product in patients with rheumatoid arthritis

por Alten, Rieke, Markland, Colin, Boyce, Malcolm, Kawakami, Kazuki, Muniz, Rafael, Genovese, Mark C.
Publicado 2020

Response to baricitinib therapy in patients with rheumatoid arthritis with inadequate response to csDMARDs as a function of baseline characteristics

por Kremer, Joel M, Schiff, Michael, Muram, David, Zhong, Jinglin, Alam, Jahangir, Genovese, Mark C
Publicado 2018

The Incidence, Prevalence, and Associated Costs of Anemia, Malignancy, Venous Thromboembolism, Major Adverse Cardiovascular Events, and Infections in Rheumatoid Arthritis Patients...

por Dore, Robin K., Antonova, Jenya N., Burudpakdee, Chakkarin, Chang, Lawrence, Gorritz, Magdaliz, Genovese, Mark C.
Publicado 2021

Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept

por Alten, Rieke, Bingham, Clifton O., Cohen, Stanley B., Curtis, Jeffrey R., Kelly, Sheila, Wong, Dennis, Genovese, Mark C.
Publicado 2016

Safety results of ixekizumab with 1822.2 patient-years of exposure: an integrated analysis of 3 clinical trials in adult patients with psoriatic arthritis

por Combe, Bernard, Rahman, Proton, Kameda, Hideto, Cañete, Juan D., Gallo, Gaia, Agada, Noah, Xu, Wen, Genovese, Mark C.
Publicado 2020

Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies

por Genovese, Mark C., Durez, Patrick, Fleischmann, Roy, Tanaka, Yoshiya, Furst, Daniel, Yamanaka, Hisashi, Korneva, Elena, Vasyutin, Igor, Takeuchi, Tsutomu
Publicado 2021

Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis

por Burmester, Gerd R, Landewé, Robert, Genovese, Mark C, Friedman, Alan W, Pfeifer, Nathan D, Varothai, Nupun A, Lacerda, Ana P
Publicado 2017

Characterisation of the safety profile of evobrutinib in over 1000 patients from phase II clinical trials in multiple sclerosis, rheumatoid arthritis and systemic lupus erythematos...

por Montalban, Xavier, Wallace, Daniel, Genovese, Mark C, Tomic, Davorka, Parsons-Rich, Dana, Le Bolay, Claire, Kao, Amy H, Guehring, Hans
Publicado 2023

Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate

por Cohen, Stanley B, Keystone, Edward, Genovese, Mark C, Emery, Paul, Peterfy, Charles, Tak, Paul Peter, Cravets, Matt, Shaw, Tim, Hagerty, David
Publicado 2010

Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial

por Conaghan, Philip G, Emery, Paul, Østergaard, Mikkel, Keystone, Edward C, Genovese, Mark C, Hsia, Elizabeth C, Xu, Weichun, Rahman, Mahboob U
Publicado 2011

Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: week 52 results from SPIRIT-P2

por Genovese, Mark C, Combe, Benard, Kremer, Joel M, Tsai, Tsen-Fang, Behrens, Frank, Adams, David H, Lee, Chin, Kerr, Lisa, Nash, Peter
Publicado 2018

Tissue metabolite of type I collagen, C1M, and CRP predicts structural progression of rheumatoid arthritis

por Bay-Jensen, Anne C., Platt, Adam, Jenkins, Martin A., Weinblatt, Michael E., Byrjalsen, Inger, Musa, Kishwar, Genovese, Mark C., Karsdal, Morten A.
Publicado 2019

Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation

por Kirkham, Bruce W, Wasko, Mary Chester, Hsia, Elizabeth C, Fleischmann, Roy M, Genovese, Mark C, Matteson, Eric L, Liu, Hongjuan, Rahman, Mahboob U
Publicado 2014

Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insuf...

por Fleischmann, Roy M, Genovese, Mark C, Enejosa, Jeffrey V, Mysler, Eduardo, Bessette, Louis, Peterfy, Charles, Durez, Patrick, Ostor, Andrew, Li, Yihan, Song, In-Ho
Publicado 2019

Pooled analysis of TNF inhibitor biosimilar studies comparing radiographic progression by disease activity states in rheumatoid arthritis

por Smolen, Josef S, Choe, Jung-Yoon, Weinblatt, Michael E, Emery, Paul, Keystone, Edward, Genovese, Mark C, Myung, Gihyun, Hong, Evelyn, Baek, Inyoung, Ghil, Jeehoon
Publicado 2020